Alexandre Golovanov v. Innate Pharma SA et al: Class Action Complaint

Class Action Complaint alleging fraud in Alexandre Golovanov v. Innate Pharma S.A., described as being a French company that “purports to be a clinical-stage biotechnology company engaged in discovering and developing first-in-class therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients” and whose securities were listed on NASDAQ; Mondher Mahjoubi, and Laure-Helene Mercieret at the U. S. District Court for the Central District of California.